|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 120.85 EUR | +1.21% |
|
+4.18% | -13.62% |
| 12-03 | Merck KGaA Rebounds Sharply as Exane Drops Skepticism and Issues Positive Recommendation | DP |
| 12-03 | Physiomics plc Announces Board Changes, Effective 29 May 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Specialty & Advanced Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 61.02B | |||||
| 8.57B | |||||
| 7.45B | |||||
| 7.12B | |||||
| 5.94B | |||||
| 4.38B |
- Stock Market
- Equities
- MRK Stock
- Charts Merck KGaA
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition